-
Product Insights
Glympse Bio Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Glympse Bio Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Glympse Bio Inc (Glympse Bio) is a biotechnology company that focuses on developing medical devices to diagnose and monitor inflammation and fibrotic, oncological indications and autoimmune diseases. It is investigating non-invasive biosensors to detect NASH (non-alcoholic steatohepatitis) by measuring changes in liver-associated protease activity. The company is also developing diagnostic devices to identify hepatocellular carcinoma (HCC),and tunable biosensors to...
-
Product Insights
Liver Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Liver Cancer Diagnostic Tests include assays of mostly antibodies released in response to a liver cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Liver Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Liver Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...